Empery Asset Management’s Lexaria Bioscience Warrant LEXXW Stock Holding History

Empery Asset Management’s Portfolio LEXXW Stock Details LEXXW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$74K	Hold	126,215	–	–	0.44%	29
2022 Q2	$88K	Sell	126,215 -4,467	-3%	-$3.91K	0.48%	21
2022 Q1	$118K	Sell	130,682 -2,651	-2%	-$2.99K	0.55%	25
2021 Q4	$204K	Buy	+133,333	New	+$261K	0.43%	29

Other funds holding LEXXW

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Empery Asset Management's LEXXW Position: Q3 2022 in Review

Empery Asset Management held its Lexaria Bioscience Warrant (LEXXW) position steady in Q3 2022 at 126,215 shares worth $74K. The position accounts for 0.44% of the portfolio, ranked #29.

Empery Asset Management first reported a position in LEXXW in Q4 2021 and has held it in 4 quarters since. The position peaked at $204K in Q4 2021. 4 funds tracked by Wall St. Rank hold LEXXW as of Q3 2022.

Empery Asset Management held 126,215 shares of Lexaria Bioscience Warrant worth $74K as of Q3 2022.
Empery Asset Management left its Lexaria Bioscience Warrant share count unchanged in Q3 2022.
Lexaria Bioscience Warrant made up 0.44% of Empery Asset Management's portfolio in Q3 2022, its #29 holding.
Empery Asset Management first reported a position in Lexaria Bioscience Warrant in Q4 2021 and has held it in 4 quarters since.
Empery Asset Management's Lexaria Bioscience Warrant position peaked at $204K in Q4 2021.
4 funds tracked by Wall St. Rank held Lexaria Bioscience Warrant as of Q3 2022.

Based on Empery Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.